ScienceDaily (Apr. 15, 2010) — In a major step toward predicting adverse drug reactions, systems biologists at Mount Sinai School of Medicine in New York City have integrated genetic, cellular and clinical information to find out why certain medicines can trigger fatal heart arrhythmias. The new framework could be used to study other cardiac disorders and certain neurological diseases, including epilepsy and autism, and could aid the advance of personalized medicine.
